Medline Industries, LP vs Novartis Pharmaceuticals Corp.: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 266 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Novartis Pharmaceuticals Corp..

Medline Industries, LP: 0 warning letters, 266 recalls, 0 approval records, 0 Form 483s.

Novartis Pharmaceuticals Corp.: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Side by side

Medline Industries, LP — Warning letters0

Novartis Pharmaceuticals Corp. — Warning letters0

Medline Industries, LP — Recalls266

Novartis Pharmaceuticals Corp. — Recalls1

Medline Industries, LP — Approval records0

Novartis Pharmaceuticals Corp. — Approval records0

Medline Industries, LP — Form 483s0

Novartis Pharmaceuticals Corp. — Form 483s0

Timeline

Medline Industries, LP

Most recent FDA action: July 8, 2026

Full history →

Novartis Pharmaceuticals Corp.

Most recent FDA action: September 27, 2023

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Medline Industries, LP vs Novartis Pharmaceuticals Corp.: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/medline-industries-lp-vs-novartis-pharmaceuticals-corp

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗